Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peanut power: could a simple supplement improve elderly health?

NCT ID NCT06773975

Disease control Sponsor: University of Ghana Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a peanut-based nutritional supplement could improve health in adults aged 60 and older living in peri-urban Ghana. Over 12 weeks, 81 participants either took the supplement daily or served as a control group. Researchers measured weight, blood pressure, hand grip strength, and blood markers like albumin and hemoglobin to see if the supplement made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peanut-based oral nutritional supplement
What this could lead to
If it works, this could point toward a simple, affordable way to improve nutrition and health in older adults.
What could go wrong
This is a small, early pilot study with only 81 participants. Results may not apply to other groups, and the supplement may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

81 people

The number who actually took part.

Started

Nov 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Elderly individuals aged 60 years and above * Consent to participate Exclusion Criteria: * Peanut allergy * Millet allergy * Sesame seeds allergy * The use of oral nutritional supplement * Sickle cell disease * End stage and terminal illness (cancer, stroke, liver disease, dialysis) * Clinical depression * Speech impairment * Hearing impairment * Visual impairment * Cognitive impairment Screening/for cognitive impairment; the Abbreviated Mental Test Score by HODKINSON (1972) was adapted for use.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anaemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anemia Body Weight hypertensive disorder Iron Deficiencies iron deficiency anemia Protein Deficiency protein S deficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anaemia Body weight Hand grip strength Hypertension Iron-deficiency Protein deficiency Total cholesterol

Contacts and locations

Locations

  • University of Ghana

    Accra, Greater Accra Region, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.